These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28133835)

  • 1. Cut-off value of nuchal translucency as indication for chromosomal microarray analysis.
    Maya I; Yacobson S; Kahana S; Yeshaya J; Tenne T; Agmon-Fishman I; Cohen-Vig L; Shohat M; Basel-Vanagaite L; Sharony R
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):332-335. PubMed ID: 28133835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of copy number variation by CMA in fetus with increased nuchal translucency].
    Du L; Xie HN; Zheng J; He M
    Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):671-676. PubMed ID: 30369122
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.
    Su L; Huang H; An G; Cai M; Wu X; Li Y; Xie X; Lin Y; Wang M; Xu L
    Mol Genet Genomic Med; 2019 Aug; 7(8):e811. PubMed ID: 31209990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal microarray as primary diagnostic genomic tool for pregnancies at increased risk within a population-based combined first-trimester screening program.
    Vogel I; Petersen OB; Christensen R; Hyett J; Lou S; Vestergaard EM
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):480-486. PubMed ID: 28608362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
    Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal microarray analysis in fetuses with aberrant right subclavian artery.
    Maya I; Kahana S; Yeshaya J; Tenne T; Yacobson S; Agmon-Fishman I; Cohen-Vig L; Levi A; Reinstein E; Basel-Vanagaite L; Sharony R
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):337-341. PubMed ID: 27063194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
    Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of chromosomal microarray in fetuses with increased nuchal translucency.
    Zhao XR; Gao L; Wu Y; Wang YL
    J Matern Fetal Neonatal Med; 2020 May; 33(10):1749-1754. PubMed ID: 30688128
    [No Abstract]   [Full Text] [Related]  

  • 10. Chromosomal microarray in fetuses with increased nuchal translucency.
    Lund IC; Christensen R; Petersen OB; Vogel I; Vestergaard EM
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):95-100. PubMed ID: 25393210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What would be missed in the first trimester if nuchal translucency measurement is replaced by cell free DNA foetal aneuploidy screening?
    Huang LY; Pan M; Han J; Zhen L; Yang X; Li DZ
    J Obstet Gynaecol; 2018 May; 38(4):498-501. PubMed ID: 29433355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of prenatal screening with nuchal translucency > 95th centile and below 99th centile: a 4-year observational study with real-world data.
    Zhang B; Zhang LX; Yi J; Wang CH; Zhao Y
    Arch Gynecol Obstet; 2024 Sep; 310(3):1779-1785. PubMed ID: 38625542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of fetuses with increased nuchal translucency using an approach based on quantitative fluorescent polymerase chain reaction and genomic microarray.
    Pan M; Han J; Zhen L; Yang X; Li R; Liao C; Li DZ
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():164-7. PubMed ID: 26771907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic yield of chromosomal microarray analysis in fetuses with isolated increased nuchal translucency: a French multicenter study.
    Egloff M; Hervé B; Quibel T; Jaillard S; Le Bouar G; Uguen K; Saliou AH; Valduga M; Perdriolle E; Coutton C; Coston AL; Coussement A; Anselem O; Missirian C; Bretelle F; Prieur F; Fanget C; Muti C; Jacquemot MC; Beneteau C; Le Vaillant C; Vekemans M; Salomon LJ; Vialard F; Malan V
    Ultrasound Obstet Gynecol; 2018 Dec; 52(6):715-721. PubMed ID: 29027723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of chromosomal microarray analysis in prenatal diagnosis of fetuses with increased nuchal translucency].
    Ni M; Li J; Zhu X; Zhu Y; Gu L; Wu X; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct; 36(10):970-974. PubMed ID: 31598938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Examination for Fetuses with Increased Fetal Nuchal Translucency by Genomic Technology.
    Xue S; Yan H; Chen J; Li N; Wang J; Liu Y; Zhang H; Li S; Zhang W; Chen D; Chen M
    Cytogenet Genome Res; 2020; 160(2):57-62. PubMed ID: 32036363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole exome sequencing in fetuses with isolated increased nuchal translucency: a systematic review and meta-analysis.
    Di Girolamo R; Rizzo G; Khalil A; Alameddine S; Lisi G; Liberati M; Novelli A; D'Antonio F
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2193285. PubMed ID: 37019452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal microarray analysis versus noninvasive prenatal testing in fetuses with increased nuchal translucency.
    Wang C; Tang J; Tong K; Huang D; Tu H; Zhu J
    J Hum Genet; 2022 Sep; 67(9):533-539. PubMed ID: 35578003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic yield of next-generation sequencing in fetuses with isolated increased nuchal translucency: systematic review and meta-analysis.
    Pauta M; Martinez-Portilla RJ; Borrell A
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):26-32. PubMed ID: 34309942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.